Safety and efficacy of Skin care formulatio
- Registration Number
- CTRI/2022/04/042231
- Lead Sponsor
- Kama Ayurveda Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Indian male and female subjects
2)Healthy subjects
3)Between 18 and 45 years of age.
4)Skin is healthy on the studied anatomic unit
5)Having oily & mixed oily skin and combination skin type with acne lesions, blackhead, whiteheads & visible pores
1)For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
2)Having refused to give his/her assent by signing the consent form
3)Taking part in another study liable to interfere with this study
4)In the 6 previous months
Having started, changed or stopped a hormonal treatment,
Having taken an oral retinoid-based treatment.
5)In the previous month
Having undergone a physical or chemical treatment for acne,
Having had a local benzoyl-peroxide-based treatment or a local retinoid-based treatment,
Having had an oral treatment with a base of cimetidine, zinc or spironolactone
6)In the 2 previous weeks
Having applied cosmetic products with anti-seborrheic aims or cosmetics for oily skin,
Having had oral or local antibiotic treatment for acne,
Having had beauty treatment,
Having a suntanned skin on the studied areas which could interfere with the evaluations of the study
7)Refusing to follow the restrictions below during the study
Do not apply cosmetic products with anti-seborrheic aims or cosmetics for oily skin ,
Do not have beauty treatment,
Do not start, change or stop a hormonal treatment,
Do not start a local or general treatment acting on seborrhoea,
Do not expose himself/herself to the sun,
Strictly avoid sun exposure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method